Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats

References

• KatzOBarzilayESkaatAHermanAMittelmanMNeumannDErythropoietin induced tumour mass reduction in murine lymphoproliferative modelsActa Haematol2005114317717916227685
   PubMed Web of Science ®Google Scholar
• EschbachJWKellyMRHaleyNRAbelsRIAdamsonJWTreatment of the anemia of progressive renal failure with recombinant human erythropoietinN Engl J Med198932131581632747747
   PubMed Web of Science ®Google Scholar
• BirgegardGAaproMSBokemeyerCCancer-related anemia: pathogenesis, prevalence and treatmentOncology200568Suppl 131115855811
   PubMedGoogle Scholar
• MaieseKChongZZShangYCWangSErythropoietin: new directions for the nervous systemInt J Mol Sci2012139111021112923109841
   PubMed Web of Science ®Google Scholar
• OgilvieMYuXNicolas-MetralVErythropoietin stimulates proliferation and interferes with differentiation of myoblastsJ Biol Chem200027550397543976110995753
   PubMed Web of Science ®Google Scholar
• NishimuraKTokidaMKatsuyamaHNakagawaHMatsuoSThe effect of hemin-induced oxidative stress on erythropoietin production in HepG2 cellsCell Biol Int201438111321132924962609
   PubMed Web of Science ®Google Scholar
• ParsaCJMatsumotoAKimJA novel protective effect of erythropoietin in the infarcted heartJ Clin Invest20031127999100714523037
   PubMed Web of Science ®Google Scholar
• NairzMSonnweberTSchrollATheurlIWeissGThe pleiotropic effects of erythropoietin in infection and inflammationMicrobes Infect201214323824622094132
   PubMed Web of Science ®Google Scholar
• TuzcuABahceciMYilmazEBahceciSTuzcuSThe comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietinHorm Metab Res2004361071672015523598
   PubMed Web of Science ®Google Scholar
• SchenaFPGesualdoLPathogenetic mechanisms of diabetic nephropathyJ Am Soc Nephrol200516Suppl 1S30S3315938030
   PubMed Web of Science ®Google Scholar
• OhkuboYKishikawaHArakiEIntensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Res Clin Pract19952821031177587918
   PubMed Web of Science ®Google Scholar
• ShahSVBaligaRRajapurkarMFonsecaVAOxidants in chronic kidney diseaseJ Am Soc Nephrol2007181162817167116
   PubMed Web of Science ®Google Scholar
• KristensenPLPedersen-BjergaardUKjaerTWInfluence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trialPLoS One201384e5967223577069
   PubMed Web of Science ®Google Scholar
• AllegraVMartimbiancoLVasileALipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and dietNephrol Dial Transplant19971259249329175044
   PubMed Web of Science ®Google Scholar
• CaillaudCMechtaMAingeHChronic erythropoietin treatment improves diet-induced glucose intolerance in ratsJ Endocrinol20152252778825767056
   PubMed Web of Science ®Google Scholar
• MaieseKErythropoietin and diabetes mellitusWorld J Diabetes20156141259127326516410
   PubMed Web of Science ®Google Scholar
• KatzOStuibleMGolishevskiNErythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine modelsJ Endocrinol20102051879520061512
   PubMed Web of Science ®Google Scholar
• FurmanBLStreptozotocin-induced diabetic models in mice and ratsCurr Protoc Pharmacol2015705.47.12026331889
   PubMedGoogle Scholar
• ChengJTHuangCCLiuIMTzengTFChangCJNovel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic ratsDiabetes200655381982516505249
   PubMed Web of Science ®Google Scholar
• SatoKKitamuraTKawamuraGGlucose use in fasted rats under sevoflurane anesthesia and propofol anesthesiaAnesth Analg2013117362763323868888
   PubMed Web of Science ®Google Scholar
• GulatiVHardingIHPalomboEAEnzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemiaBMC Complement Altern Med2012127722713130
   PubMed Web of Science ®Google Scholar
• BordSIrelandDCMoffattPThomasGPCompstonJECharacterization of osteocrin expression in human boneJ Histochem Cytochem200553101181118715923362
   PubMed Web of Science ®Google Scholar
• CiardielloFTortoraGEGFR antagonists in cancer treatmentN Engl J Med2008358111160117418337605
   PubMed Web of Science ®Google Scholar
• LiYXChengKCAsakawaARole of musclin in the pathogenesis of hypertension in ratPLoS One201388e7200423940802
   PubMed Web of Science ®Google Scholar
• ShoriABScreening of antidiabetic and antioxidant activities of medicinal plantsJ Integr Med201513529730526343100
   PubMedGoogle Scholar
• Rjiba-TouatiKAyed-BoussemaIGuedriYAchourABachaHAbid-EssefiSEffect of recombinant human erythropoietin on mitomycin C-induced oxidative stress and genotoxicity in rat kidney and heart tissuesHum Exp Toxicol2016351536225733728
   PubMed Web of Science ®Google Scholar
• ChoKChungJYChoSKAntihyperglycemic mechanism of metformin occurs via the AMPK/LXRalpha/POMC pathwaySci Rep20155814525634597
   PubMed Web of Science ®Google Scholar
• GagnonJSheppardEAniniYMetformin directly inhibits ghrelin secretion through AMP-activated protein kinase in rat primary gastric cellsDiabetes Obes Metab201315327627923066988
   PubMed Web of Science ®Google Scholar
• McGeeSLvan DenderenBJHowlettKFAMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5Diabetes200857486086718184930
   PubMed Web of Science ®Google Scholar
• Montel-HagenASitbonMTaylorNErythroid glucose transportersCurr Opin Hematol200916316517219346941
   PubMed Web of Science ®Google Scholar
• ScullyMSOrtTAJamesIEA novel EPO receptor agonist improves glucose tolerance via glucose uptake in skeletal muscle in a mouse model of diabetesExp Diabetes Res2011201191015921754921
   PubMedGoogle Scholar
• Rodriguez-CalvoRVazquez-CarreraMMasanaLNeumannDAICAR protects against high palmitate/high insulin-induced intramyocellular lipid accumulation and insulin resistance in HL-1 cardiac cells by inducing PPAR-target gene expressionPPAR Res2015201578578326649034
   PubMed Web of Science ®Google Scholar
• ConsoliANurjhanNCapaniFGerichJPredominant role of gluconeogenesis in increased hepatic glucose production in NIDDMDiabetes19893855505572653926
   PubMed Web of Science ®Google Scholar
• KourySTBondurantMCKouryMJSemenzaGLLocalization of cells producing erythropoietin in murine liver by in situ hybridizationBlood19917711249725032039831
   PubMed Web of Science ®Google Scholar
• YuanYHakimiPKaoCReciprocal changes in phosphoenolpyruvate carboxykinase and pyruvate kinase with age are a determinant of aging in caenorhabditis elegansJ Biol Chem201629131307131926631730
   PubMed Web of Science ®Google Scholar
• KuoYHLinCHShihCCCaffeamide 36-13 regulates the antidiabetic and hypolipidemic signs of high-fat-fed mice on glucose transporter 4, AMPK phosphorylation, and regulated hepatic glucose productionEvid Based Complement Alternat Med2014201482156925140189
   PubMed Web of Science ®Google Scholar
• WangLDiLNoguchiCTErythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid systemInt J Biol Sci201410892193925170305
   PubMed Web of Science ®Google Scholar
• HeijLNiestersMSwartjesMSafety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot studyMol Med2012181430143623168581
   PubMed Web of Science ®Google Scholar
• Sanchis-GomarFPerez-QuilisCLippiGErythropoietin receptor (EpoR) agonism is used to treat a wide range of diseaseMol Med201319626423615965
   PubMed Web of Science ®Google Scholar